Arteris Q4 2025 Earnings Report

Arteris EPS Results

• Actual EPS: -$0.05
• Consensus EPS: -$0.08
• Beat/Miss: Beat by +$0.03
• One Year Ago EPS: N/A

Arteris Revenue Results

• Actual Revenue: $20.14 million
• Expected Revenue: $18.55 million
• Beat/Miss: Beat by +$1.59 million
• YoY Revenue Growth: N/A

Arteris Announcement Details

• Quarter: Q4 2025
• Date: 2/12/2026
• Time: After Market Closes
• Conference Call Date: Thursday, February 12, 2026
• Conference Call Time: 4:30PM ET

Arteris (NASDAQ:AIP) is a semiconductor intellectual property company that provides network-on-chip (NoC) interconnect and system IP for the design of complex systems-on-chip (SoCs). Its technologies help semiconductor and electronics companies connect processor cores, memory, peripherals and other functional blocks within a chip while supporting data movement, system integration and design reuse.

The company’s product portfolio includes FlexNoC interconnect IP, Ncore cache-coherent interconnect IP and CodaCache system IP. Arteris also provides tools and related technologies intended to simplify SoC architecture, integration, verification and configuration. Its solutions are used in applications such as automotive electronics, artificial intelligence and high-performance computing, consumer devices, communications equipment and industrial systems.

Arteris was founded in 2003 and is headquartered in Campbell, California. The company serves semiconductor developers and systems companies internationally and became a publicly traded company on the Nasdaq under the symbol AIP in 2021. Arteris has been led by K. Charles Janac, who serves as president and chief executive officer.

Arteris Q4 2025 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: Record commercial momentum — Arteris reported ACV plus royalties of $83.6M (+28% YoY), Q4 revenue of $20.1M (+30% YoY), and RPO of $117M (+32% YoY), with variable royalties up ~50% YoY.
• Positive Sentiment: Strong profitability and balance sheet — Non‑GAAP gross margin was ~92%, the company finished with $59.5M in cash and no debt, and generated positive free cash flow for the year.
• Positive Sentiment: Acquisition of Cycuity — Closed Jan 14, 2026, adding semiconductor cybersecurity assurance tools that expand addressable market and cross‑sell opportunities (guidance includes ~ $7M revenue from Cycuity in 2026, with a modest ~ $1M expected near‑term drag and ~1–2pp gross margin accounting impact).
• Positive Sentiment: Bullish 2026 outlook and path to profitability — Guidance targets ACV exit of $100–104M and revenue of $89–93M (including Cycuity), with management expecting a non‑GAAP operating profit as early as Q4 2026.
• Positive Sentiment: Product and customer momentum — AI‑focused products like FlexGen (licensed for 30+ production deployments) and Ncore/FlexNoC saw increased adoption by customers such as AMD, NXP, Black Sesame and Blaize, while chiplet projects using Arteris tech have more than tripled in two years.

Presentation

[Operator]

Good afternoon, everyone, and welcome to the Arteris fourth quarter and full year 2025 earnings call. Please note this call is being recorded and simultaneously webcast. All material contained in the webcast is sole property and copyright of Arteris, Inc., with all rights reserved. For opening remarks and introductions, I will now turn the call over to Erica Mannion of Sapphire Investor Relations. Please go ahead.

[Erica Mannion, Investor Relations at Sapphire Investor Relations]

Thank you, and good afternoon. With me today from Arteris are Charlie Janac, Chief Executive Officer, and Nick Hawkins, Chief Financial Officer. Charlie will begin with a brief review of the business results for the fourth quarter ended December 31, 2025. Nick will review the financial results for the fourth quarter and full year of 2025, followed by the company's outlook for the first quarter and full year of 2026. We will then open the call for questions. Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws.

[Erica Mannion, Investor Relations at Sapphire Investor Relations]

These statements are based on management's current expectations and assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties, and factors that could cause results to differ appear in the press release Arteris issued today and in the documents and reports filed by Arteris from time to time with the Securities and Exchange Commission. Please note, during this call, we will cite certain non-GAAP measures, including, among others, non-GAAP net loss, non-GAAP net loss per share, and free cash flow, which are not measures prepared in accordance with the U.S. GAAP. The non-GAAP measures are presented as we believe that they provide investors with a means of evaluating and understanding how the company's management evaluates the company's operating performance.

[Erica Mannion, Investor Relations at Sapphire Investor Relations]

These non-GAAP measures should not be considered in isolation from, as substitutes for, or superior to financial measures prepared in accordance with U.S. GAAP. A reconciliation of these non-GAAP measures to the nearest GAAP measure can be found in the press release for the quarter ended December 31, 2025. In addition, for a definition of certain of the key performance indicators used in this presentation, such as annual contract value, confirmed design starts, and remaining performance obligations, please see the press release for the quarter ended December 31, 2025. These key performance indicators are presented for supplemental informational purposes only and should not be considered a substitute for financial information presented in accordance with GAAP and may differ from similarly titled metrics or measures used by other companies, securities analysts, or investors.

[Erica Mannion, Investor Relations at Sapphire Investor Relations]

Listeners who do not have a copy of the press release for the quarter ended December 31, 2025, may obtain a copy by visiting the investor relations section of the company's website. In addition, management will be referring to the fourth quarter 2025 earnings presentation, which can be found in the investor relations section of the company's website under the Events and Presentations tab. Now, I will turn the call over to CEO, Charlie Janac.

[Charlie Janac, CEO at Arteris]

Thank you, Erica, and thanks to everyone for joining us on our call today. In the fourth quarter of 2025, we achieved many company records and milestones, including yet another record annual contract value plus royalties of $83.6 million, which represents a 28% year-on-year increase. This success was driven across our major vertical markets, with the largest impacts in enterprise computing, automotive, and consumer electronics markets, but also across other applications, including communications, industrial, and aerospace and defense. Overall, we are seeing expanding proliferation of AI-driven semiconductor designs from data center to the edge, as well as physical AI, which in turn drives increased deployment of Arteris technology.

[Charlie Janac, CEO at Arteris]

Given the combination of the rising demand for efficient data movement in semiconductors in the AI era and our expanding set of innovative products that successfully meet the growing needs of our customers, I am proud to announce that our customers have now shipped over 4 billion chips and chiplets, incorporating Arteris' Network-on-Chip IP as the underlying interconnect. This continues to positively impact our royalty revenue stream. On January fourteenth, we closed the acquisition of Cycuity, a leading provider of semiconductor cybersecurity assurance products. Cycuity brings a rich history of strong collaborations with major commercial semiconductor companies, as well as companies in the national security sector, such as Booz Allen Hamilton and National Laboratories. The addition of Cycuity's technology and expertise strengthens the Arteris product portfolio, enabling chip designers to analyze and improve security in IP blocks, chiplets, and SoCs.

[Charlie Janac, CEO at Arteris]

Cycuity products enable the early detection of cybersecurity risks in the semiconductor hardware and firmware that serve as the foundation for all application software. The Cycuity products enable customers to uncover hardware, security weaknesses, and potential vulnerabilities, and help to reduce associated security risks during the design phase prior to silicon manufacturing and end device production deployment. According to the National Institute of Standards and Technology, or NIST, newly reported cybersecurity silicon vulnerabilities grew by over 15 times in the last five years, with the unreported number likely much higher.... The security acquisition will help us to address market concerns about the rapidly increasing volume of sophisticated cyberattacks, targeting the vast amounts of data moving through semiconductors, from AI data centers to networks, and a broad range of devices across the digital ecosystem.

[Charlie Janac, CEO at Arteris]

There is a growing need for cybersecurity domain expertise and proven technology, which security acquisition brings to Arteris, enabling us to proactively help customers address cybersecurity in processors and other silicon devices. We believe this product line can be used by all of our existing customers, as well as others in a broader semiconductor and systems ecosystem that are not current customers. Our vision is to bring improved hardware security and advanced vulnerability testing to all SoCs, thereby extending Arteris' reach meaningfully in terms of new customers and new entry points for every design, regardless of complexity. Moving on to our organically developed products, all of which experienced strong customer adoption in 2025.

[Charlie Janac, CEO at Arteris]

FlexGen, our AI-driven smart NoC IP product, announced a year ago, saw a strong uptick in customer adoption and has now been licensed for over 30 production device deployments across each of our vertical end markets, with customers including AMD for AI chiplet designs, GreenChip for automotive, and NanoXplore for aerospace applications. FlexGen's initial success reflects the growing need for optimized chip designs for lower power usage and latency, combined with accelerated development cycles. This is particularly true for complex SoCs and chiplet designs in today's AI era, which have high performance and low power goals and tight market windows in which to deliver silicon. Accordingly, we expect FlexGen momentum to continue in 2026. In the second half of 2025, we also saw strength in the licensing of our cache coherent interconnect IP product, Ncore, across various edge and server applications.

[Charlie Janac, CEO at Arteris]

For example, in early fourth quarter 2025, Altera selected Ncore and FlexGen products from Arteris to advance intelligence computing from cloud to edge applications. This significant order underscores Arteris' ability to support large customers across multiple of their product generations, an ability that drives our 90%+ customer retention rate. We continue to see growing adoption of our product portfolio by top technology companies and large enterprises. An example of this is NXP, which delivers purpose-built, rigorously tested technologies that enable devices to sense, think, and act intelligently. We recently announced that NXP has expanded its use of Arteris products to accelerate its edge AI efforts. NXP is deploying Arteris more broadly across its AI-enabled silicon solutions, including for intelligent vehicles, experiences on the edge. This includes our Ncore and FlexNoC network on chip IPs, CodaCache last level cache IP, and Magillem SoC integration software.

[Charlie Janac, CEO at Arteris]

NXP is using these products to develop latest AI-driven silicon designs, including SoCs, neural processing units or NPUs, and microcontrollers or MCUs, with safe and secure high-performance data movement. Another example of a recent win is Black Sesame, which also licensed both cache coherent and non-coherent interconnect IPs for their device's dual needs, with Ncore and FlexNoC being used to address the automotive industry's demand for automated driving silicon. Black Sesame develops a broad range of automotive semiconductors that spans from high-performance SoCs for AI autonomous driving to cross-domain SoCs used in a broad range of vehicles. Arteris technology provides the high-performance network-on-chip connectivity with safety that is critical for designing tomorrow's complex automotive SoCs and achieving time to market requirements. Power consumption is a key factor in new SoC designs, particularly those supporting AI workloads.

[Charlie Janac, CEO at Arteris]

In the fourth quarter, Blaize deployed Arteris system IP for their scalable, energy-efficient AI silicon. The Blaize AI platform delivers a programmable, energy-efficient foundation for hybrid AI deployment models, spanning edge and cloud infrastructure, which enables users to build multimodal AI inference for smart vision, sensing, acoustic monitoring, and real-time language understanding at the edge for industrial, transportation, and smart surveillance applications. By using Arteris interconnect IP, Blaize can ensure efficient data movement along with reduction in power consumption. AI is also increasingly driving chiplet projects. The number of chiplet projects incorporating Arteris technology more than tripled over the past two years. All of these projects require state-of-the-art Arteris technology and close collaboration with multiple ecosystem partners, which has been a major focus for us over the years.

[Charlie Janac, CEO at Arteris]

In the fourth quarter, we announced that Arteris is a founding member of the TRISTAN Project, which aims to create an open automotive chiplet platform. Led by Bosch, this initiative includes automotive OEMs such as BMW, Renault, and Stellantis, as well as automotive suppliers, semiconductor companies, EDA and software providers, and research entities, with Arteris providing Network-on-Chip expertise and chiplet and multi-die SoC interconnect technology. Arteris is also part of Cadence's recently announced strategic collaboration with Arm, Samsung Foundry, and other IP partners to deliver pre-validated chiplet solutions. The goal of this initiative is to reduce engineering complexity and accelerate time to market for mutual customers developing chiplets, targeting physical AI, data centers, and high-performance computing or HPC application, with Arteris interconnect IP enabling the underlying data movement. Our customers continue to innovate in exciting growth areas such as AI-enabled chips and chiplets, from data centers to edge devices.

[Charlie Janac, CEO at Arteris]

The same is true for physical AI, which is based on foundation of silicon, combining computing, sensing, and data movement to interact with the real world. physical AI requires a combination of quality, high performance, energy efficiency, functional safety, and cybersecurity, among others, which is supported by our products. Overall, Arteris is in a strong position to support semiconductor applications in the AI era across enterprise computing infrastructure, autonomous vehicle decision-making, advanced communication, smarter consumer electronics, industrial automation, and aerospace and defense use cases. With the addition of Cycuity to our product offering, we have the opportunity to become a leader in SoC security solutions for our existing customer base, as well as a door opener to other companies who design SoCs, thereby helping us to realize our mission of enabling every design with leading-edge Arteris technology.

[Charlie Janac, CEO at Arteris]

With that, I'll turn it over to Nick to discuss our financial results in more detail.

[Nick Hawkins, CFO at Arteris]

Thank you, Charlie, and good afternoon, everyone. As I review our fourth quarter and full year results for 2025 today, please note I'll be referring to GAAP as well as non-GAAP metrics. Please note that our reconciliation of GAAP to non-GAAP financials is included in today's earnings release, which is available on our website. Also, as a reminder, I will be referring to the 4Q 2025 earnings presentation, which can be found in the investor relations section of the company's website under the Events and Presentations tab. We had a strong fourth quarter, beating our guidance on all financial measures. The security acquisition closed in January 2026. Therefore, the security financial performance is not included in any of our reported results for 2025.

[Nick Hawkins, CFO at Arteris]

However, our guidance for the first quarter and the full year 2026 incorporates the expected financial results of the security business from January 14, 2026 onwards. Turning to slide 5 of the presentation. Total revenue for the fourth quarter was $20.1 million, up 16% sequentially and 30% year-over-year, and above the top end of our guidance range. For the full year 2025, total revenue was $70.6 million, 22% higher year-over-year. Notably, variable royalties was 50% higher year-over-year, with the fourth quarter setting a new record. Our royalty stream today is fueled by a balanced mix of customers across all our vertical markets, with the number of large royalty reporters tripling in the last 2 years.

[Nick Hawkins, CFO at Arteris]

At the end of the fourth quarter, annual contract value plus royalties was $83.6 million, up 28% year over year, above the top end of our guidance range and at a new record high. Remaining performance obligations, or RPO, which is our contracted future revenue at the end of the fourth quarter, totaled $117 million, representing a 32% year-over-year increase, another record high for the company. As disclosed in the notes to our financial statements, we expect approximately half of our RPO will be recognized as revenue in 2026. This projection excludes cancelable and non-cancelable FSA. Non-GAAP gross profit in the quarter was $18.5 million, representing a gross margin of 92%. GAAP gross profit in the quarter was $18.3 million, representing a gross margin of 91%.

[Nick Hawkins, CFO at Arteris]

For the full fiscal year, non-GAAP gross profit was $64.8 million, representing a gross margin of 92%. GAAP gross profit was $63.7 million, representing a gross margin of 90%. Now turning to Slide 6. Non-GAAP operating expense in the quarter was $20.8 million. We continued to reinvest a portion of our top-line growth into technology innovations, customer solution support, and our global sales team. Total GAAP operating expense for the fourth quarter was $26.7 million, which included acquisition-related expenses of $1.4 million in the fourth quarter. For the full fiscal year, non-GAAP operating expense, which excludes the Cycuity acquisition expenses, was $77.2 million, representing an increase of 14% from the prior year.

[Nick Hawkins, CFO at Arteris]

This was broadly in line with our long-term goal to manage the rate of increase in non-GAAP operating expense to around half that of the rate of increase in revenue. GAAP operating expense for the year was $96.8 million. We believe that our ongoing investments will help accelerate our top-line growth in the coming years. At the same time, we are delivering operating leverage by controlling G&A spending, which has now remained broadly flat on a non-GAAP basis for over three years. This has resulted in 8 percentage point year-over-year improvement on non-GAAP operating margin. Non-GAAP operating loss in the quarter was $2.2 million, also above the top end of our guidance range.

[Nick Hawkins, CFO at Arteris]

For the full 2025 fiscal year, non-GAAP operating loss was $12.5 million, representing a $2.4 million dollar improvement over the result for the prior year and at the top end of our guidance range. GAAP operating loss for the fourth quarter was $8.5 million, compared to a loss of $7.1 million in the prior year period. For the full year, GAAP operating loss was $33.1 million. Non-GAAP net loss in the quarter was $2.3 million, or diluted net loss per share of $0.05, based on approximately 43.7 million weighted average diluted shares outstanding. GAAP net loss in the quarter was $8.5 million, or diluted net loss per share of $0.19.

[Nick Hawkins, CFO at Arteris]

For the full fiscal year, non-GAAP net loss was $14.1 million, or diluted net loss per share of $0.33, based on approximately 42.3 million weighted average diluted shares outstanding. GAAP net loss for 2025 was $34.7 million, or diluted net loss per share of $0.82. Moving to slide 7 and turning to the balance sheet and cash flow. We ended the year with $59.5 million in cash, cash equivalents, and investments, and we have no financial debt. Free cash flow, which includes capital expenditure, was positive $3 million for the fourth quarter and positive $5.3 million for the full year, close to the top end of our guidance range.

[Nick Hawkins, CFO at Arteris]

I would now like to turn to our outlook for the first quarter and the full year 2026 and refer now to slide 8. For the first quarter of 2026, we expect ACV plus royalties of $85 million-$89 million, revenue of $20.5 million-$21.5 million, with non-GAAP operating loss of $3.5 million-$2.5 million and non-GAAP free cash flow of negative $1.5 million to positive $1.5 million. For the full year 2026, our guidance is as follows: ACV plus royalties to exit 2026 at $100 million-$104 million. Revenue of $89 million-$93 million, including approximately $7 million from the security business.

[Nick Hawkins, CFO at Arteris]

Noting that the majority of revenue derived from the Cycuity business we expect to be ratable. Non-GAAP operating loss of between $9 million-$5 million, approximately $1 million of which we expect to be related to the Cycuity acquisition. Non-GAAP free cash flow of $5 million-$9 million. Building on the strong deal execution in 2025, illustrated by the 32% year-over-year growth in RPO exiting the fourth quarter and incorporating the anticipated growth in Cycuity's semiconductor cybersecurity assurance software business, we continue to believe that Arteris is on a path to profitability, as we expect to report a non-GAAP operating profit for a period as early as the fourth quarter of 2026. With that, I will turn the call back to the operator for the Q&A portion of our call. Operator?

[Operator]

Thank you. Ladies and gentlemen, we will now begin the question-and-answer session. To join the question queue, you may press Star then one on your touchtone phone. You will hear a tone acknowledging your request. If you are using a speakerphone, please pick up your handset before pressing any keys. To withdraw your question, please press Star then two. We will pause for a moment as callers join the queue. We have a question from Kevin Garrigan from Jefferies. Your line is open. We have a question from Madison DePaula from Rosenblatt Securities. Your line is open.

[Madison DePaula, Analyst at Rosenblatt Securities]

Can you help us size the cross-sell opportunities by outlining which customer segments you expect to engage first and kind of expand on how security changes your ability to increase content per customer over time?

[Charlie Janac, CEO at Arteris]

Yeah. So, you know, hardware security assurance is becoming a major issue. As we said on the earnings call, there's about a 15x growth in sort of hardware attacks, security attacks on semiconductors. So hardware security is becoming a major issue. And because of that, we're very excited about the security hardware assurance software, because not only can it be used by our substantially larger customer base, but it can be used by essentially any semiconductor company, and those chips have to be protected regardless of the complexity. So we think that it opens up a significant opportunity to essentially enhance the system IP value that we provide, but also to address basically any semiconductor out there.

[Charlie Janac, CEO at Arteris]

So we're very excited about what we have been able to accomplish, and we'll look forward to keeping you updated on our progress.

[Madison DePaula, Analyst at Rosenblatt Securities]

Okay, great. Thank you.

[Operator]

Again, if you would like to ask the question, please press Star, then one. Our next question is from Kevin Garrigan from Jefferies. Your line is open.

[Kevin Garrigan, Senior Vice President at Jefferies]

Yeah. Hey, guys, sorry about that. Congrats on the great results and outlook, and thanks for taking my questions. Hey, your NXP announcement. So NXP is now using 4 of your solutions, which I think is probably up from, you know, 1 or maybe 2. Are you seeing more interest from customers to deploy an entire suite of solutions? And I'd imagine that if you do get customers that are deploying the entire suite, that puts your licensing ASPs well above the $1 million that you kind of were targeting a couple years ago.

[Charlie Janac, CEO at Arteris]

Yeah, absolutely. And, you know, if you use everything from us, prior to the Cycuity acquisition, you're gonna be well north of $1 million, and with Cycuity, it's gonna be, you know, higher than that, right? So we basically have more to sell to our customers. And so, security is a big issue now. A lot of markets, such as automotive and aerospace and even data center, are requiring ISO 21434 certification for cybersecurity protection. And so, you know, we think that this certainly helps drive the ASP significantly above the $1 million average project size.

[Charlie Janac, CEO at Arteris]

Also, the other thing that's helping to go above the 1 million is that the chiplet projects, where you're dealing with multiple pieces of silicon, where essentially every chiplet is a license and every chiplet is a royalty, also helps that trend, right? So we're very positive about the dynamics of our business.

[Kevin Garrigan, Senior Vice President at Jefferies]

Yep, got it. That makes a ton of sense. And then, Nick, just, you know, a question for you. Can you talk a little bit more about the strength in royalties that you saw? Was there a specific end market that, you know, that saw surprising strength, or was it more just about your customer diversification strategy?

[Nick Hawkins, CFO at Arteris]

It's a little bit of both. Hi, Kevin, thanks for joining the call. You may have seen that the number of major reporters has grown from 1, 5 years ago to 3, about 2 years ago to 9 today. So those big reporters are the six-figure-plus per quarter royalty reporters. So that's a really important metric to us. And one of the issues that we look at is looking at the spread across geos and also across market verticals. And so of those, the 9 large reporters today, they're spread across several segments. There are several in the automotive segment, and that remains our largest single vertical.

[Nick Hawkins, CFO at Arteris]

But we do have now very rapidly emerging consumer enterprise and even now, aerospace, large reporters. So that I, I'm very happy that it's a broad spectrum of strength, and I look forward to some further growth in the future.

[Kevin Garrigan, Senior Vice President at Jefferies]

Yep, got it. Okay, perfect. Thanks, guys, and congrats on the results.

[Charlie Janac, CEO at Arteris]

Thank you.

[Nick Hawkins, CFO at Arteris]

Thanks, Kevin.

[Operator]

Once again, if you would like to ask the question, please press Star, then one. Our next question is from Gus Richard from Northland. Your line is open.

[Gus Richard, Managing Director at Northland]

Yes, thanks for taking the question, and congratulations on the results. In Q4, the royalties had a, you know, a significant quarter-on-quarter step up. Is there any catch-up royalty in that number, or should we expect that to be the run rate going forward or, you know, with a seasonal bias?

[Nick Hawkins, CFO at Arteris]

Yeah, no, that's, that's an excellent question, Gus, and, and welcome to the call. And this is Nick, by the way. There was a single royalty pickup, which was reasonably sized. It was less than $500,000, but that's a decent pickup, which we saw in the fourth quarter. So it did get a bit of a boost from that. So the 50% variable increase includes that. If you X them out, the growth rate year-over-year was still in the low 40s%, which is above our trajectory, and our sort of longer-term guidance for CAGR for the next five years. So we're, we're very, very happy that it's already growing at that rate.

[Nick Hawkins, CFO at Arteris]

Audits, you can never guarantee when they're going to produce a positive result for the company. When they happen, they're great, but we can't, as you rightly point out, you can't bank on them.

[Gus Richard, Managing Director at Northland]

Got it. And then, just a little bit about security and its impact on the P&L. You know, my top line went up, you know, at the midpoint of guidance, about $7 million. And then I'm just curious, you know, how much of that was security for the full year? And then, can you talk a little bit about the impact on the P&L, in terms of, you know, step-up in OpEx going forward?

[Nick Hawkins, CFO at Arteris]

Yeah, no, it's another excellent question, Gus. So, of the $91 million midpoint guide, it's $89 million-$93 million is the range for revenue in 2026. Of that $91 million, approximately $7 million is Cycuity. So, and forgive me if you can hear my dog barking in the background. So $84 million is the Arteris original business, and that represents about a 19% year-over-year growth. So as far as the rest of the financial impact from Cycuity, they do expect them to be a slight contributor to the loss for the year, so about a $1 million loss. By the fourth quarter, we expect them to be at roughly breakeven, which is in line with the pre-Cycuity addition Arteris business.

[Nick Hawkins, CFO at Arteris]

And as far as free cash flow is concerned, we're there—we're also expecting them to be something like -$1 million over the full year and about -$1.5 million in the first quarter. This often happens in acquisitions, as I'm sure you've seen before. And there is a little nuance around gross margin. Some of the government work that they do is actually involves subcontractors. And the GAAP accounting for subcontractors is that those expenses are not OpEx, they're treated as cost of revenue. So there's something like a 2 percentage point, a 1-2 percentage point drop in gross margin intensity, but that's just literally a flip between OpEx and gross margin.

[Gus Richard, Managing Director at Northland]

Okay. Got it. That was helpful. And then my last one is, when you did the security acquisition, you guys announced an ATM, and you were gonna use that to replace the cash that you used for the acquisition. And I'm just wondering, you know, where are you in that raising equity raising effort, and, you know, when can we expect that to conclude?

[Nick Hawkins, CFO at Arteris]

So, we're in the process of going through the activation, Gus. We can't activate during a quiet period, as you probably know, because obviously we have MNPI during that period before we announce our results. So we will be going through that activation process shortly. We then are going through a process of setting up the traditional guardrails. We have a pricing committee on the board, and they will agree guardrails in terms of pricing and quantum. And so we—you can expect maybe some small amounts to dribble through in the first quarter. It just really depends on how the market moves and so on.

[Nick Hawkins, CFO at Arteris]

We have no intent at the moment to utilize anything close to the full amount that's available there.

[Gus Richard, Managing Director at Northland]

Got it. Well, that was a buzzkill. Thanks for the help.

[Operator]

There are no questions at this time. I would now like to turn the conference back to Charlie for the closing remarks. Please go ahead.

[Charlie Janac, CEO at Arteris]

Okay. Thank you for your interest in Arteris. We look forward to meeting with you at the upcoming non-deal roadshow and investor conferences in the quarters ahead and updating you on our business progress. Thank you very much.

[Operator]

This concludes today's conference call. Thank you for participating. You may now disconnect.

Participants

Executives

• Charlie Janac, CEO
• Nick Hawkins, CFO

Analysts

• Erica Mannion, Investor Relations at Sapphire Investor Relations
• Gus Richard, Managing Director at Northland
• Kevin Garrigan, Senior Vice President at Jefferies
• Madison DePaula, Analyst at Rosenblatt Securities